Spinal Anesthesia Using Lidocaine and Sufentanil and (Transient Neurological Symptoms) TNS

NCT01283087 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 168

Last updated 2017-11-27

No results posted yet for this study

Summary

The purpose of this study is to find out whether patients receiving spinal anesthesia containing lidocaine and sufentanil get transient neurological symptoms.

Conditions

  • Transient Neurologic Symptoms

Sponsors & Collaborators

  • Vestre Viken Ringerike Sykehus

    lead OTHER

Principal Investigators

  • halfdan Aas, MD, PhD · Vestre Viken HF

  • halfdan Aas, MD, PhD · VestreViken HF

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01283087 on ClinicalTrials.gov